Monoclonal Antibody Therapeutics Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Chronic Diseases.

-

Monoclonal antibody therapeutics are monoclonal antibodies that are developed and utilized for treating various medical conditions like cancer, Crohn's disease, rheumatoid arthritis, multiple sclerosis and others. These antibodies help in targeting specific antigens, proteins or receptors, which helps in modulating the immune system or directly impacting disease processes. Monoclonal antibodies have advantages like high specificity and affinity for their target antigens compared to polyclonal antibodies. Some monoclonal antibody therapeutics help in directly attacking cancer cells by binding to antigens expressed on tumors or modulate the immune system to enhance the body's antitumor response.


The global monoclonal antibody therapeutics market is estimated to be valued at US$ 83.63 Bn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2024 to 2030.

Rising prevalence of chronic diseases, increased R&D spending by key players and rising demand for monoclonal antibodies with fewer side effects are some of the factors anticipated to drive high growth of the monoclonal antibody therapeutics market globally during the forecast period.

Key Takeaways

Key players operating in the monoclonal antibody therapeutics are IOI Loders Croklaan, Ghana Nuts Company Ltd., and The Savannah Fruits Company. These players are investing aggressively in developing various novel monoclonal antibody therapeutics and undertaking strategic collaborations to enhance their product portfolios.

The global monoclonal antibody therapeutics market provides numerous growth opportunities such as focus on developing monoclonal antibodies for rare and orphan diseases. Companies are also focusing on exploring new mechanisms for cancer immunotherapy with monoclonal antibodies.

Key players in the monoclonal antibody therapeutics market size are undertaking strategic initiatives like acquisitions and expansions to strengthen their presence across major markets. For instance, IOI Loders Croklaan expanded its footprint in South Africa and Ghana Nuts Company Ltd. acquired a Germany based manufacturing facility to cater to the European market.

Market Drivers
Rising prevalence of diseases like cancer, cardiac diseases and autoimmune disorders where monoclonal antibody therapeutics play a major role are a key growth driver for this market. According to WHO, cancer burden is expected to grow tremendously in the coming decades. This rising cancer incidence rate provides a huge market potential for novel monoclonal antibody therapeutics.

Market Restrains
High development and production costs of monoclonal antibodies remain a major restraint for the overall monoclonal antibody therapeutics market. Developing novel monoclonal antibody therapeutics require huge R&D investments and involves a lengthy development process. Commercial production of these antibodies also involves high capital and overhead costs. This makes these therapeutics less affordable especially in low-income regions, restricting market growth to some extent.

Segment Analysis

The Monoclonal Antibody Therapeutics market is segmented based on source, application and end user. The source segment is further divided into murine, chimeric, humanized and human. The humanized sub segment dominates the market as these antibodies have minimal immunogenicity. The application segment includes cancer, autoimmune diseases, infectious diseases, microbial diseases and others. The cancer sub segment holds the largest share due to increasing prevalence of cancer worldwide and rising adoption of monoclonal antibody therapeutics for treatment of different cancer types like breast cancer and lung cancer. The end user segment is split into hospitals, research laboratories and ASCs. Hospitals dominate the end user segment owing to availability of advanced healthcare facilities for cancer treatment in hospitals.

Global Analysis

Regionally, North America holds the highest share in the global monoclonal antibody therapeutics market due to advanced healthcare infrastructure, growing biotechnology industry and rising R&D investments. The market in Asia Pacific is expected to grow at fastest pace during the forecast period attributed to increasing healthcare spending, rising awareness about monoclonal antibody therapies and expanding biopharmaceutical industry in countries like India and China. Key players focus on Asia Pacific region to tap growth potential.

Comments

Post a Comment

Popular posts from this blog

The global Calcium Citrate Malate Market Growth Accelerated by Expanding Applications

-
Image
Calcium citrate malate is an essential mineral compound that provides calcium and supports bone health. Calcium citrate malate supplements help maintain healthy bones and teeth as we age. They support calcium absorption and distribution throughout the body. The global Calcium Citrate Malate Market is estimated to be valued at US$ 334.08 Mn in 2024 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The expanding applications of calcium citrate malate are expected to drive the market growth over the forecast period. Calcium citrate malate supplements are increasingly being used to prevent and treat osteoporosis. They are especially recommended for people who cannot digest lactose or avoid dairy products. The compound is also finding wider use in functional foods and beverages with added calcium and minerals. Manufacturers are developing various product formats like...
Read more

Labor Productivity Tracking Market Growth Accelerated by Remote Work and Digitalization Trend

-
Image
Labor productivity tracking solutions help businesses and organizations track employee productivity in real-time. These solutions offer features like time tracking, activity monitoring, goal setting, resource allocation, attendance logging, and analytics. They help enhance productivity by identifying opportunities for improvement, streamlining workflows, and ensuring employees are focused on tasks that add value. The global Labor Productivity Tracking Market is estimated to be valued at US$ 6.81 Billion in 2024 and is expected to exhibit a CAGR of 38% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The rapid adoption of remote work and digitalization trend across industries during the pandemic has been a major driver accelerating growth of the labor productivity tracking market. Many organizations have now accepted work from home and hybrid work models. Labor productivity tracking solutions help employers...
Read more

Tamponades is fastest growing segment fueling the growth of the Global Vitreous Tamponades Market

-
Image
The global Vitreous Tamponades Market is estimated to be valued at US$ 83.89 Mn in 2023 and is expected to exhibit a CAGR of 2.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview : Vitreous tamponades are substances used to seal retinal breaks and provide internal tamponade during vitrectomy surgeries. They help stabilize the retina and promote posterior vitreous detachment. The different types of tamponades include gases, silicone oils and perfluoro-n-octane. Market key trends : One of the key trends in the market is the preference for non-silicone tamponades over traditional silicone oils. Silicone oils have been commonly used but are difficult to remove and can cause complications. Newer tamponades such as perfluorocarbon liquids and gases provide effective internal tamponade with better removal properties. They minimize complications and improve surgical outcomes leading to their increased demand. Segment ...
Read more